FDA Inspection 868614 — Biotest Pharmaceuticals Corp.

Biotest Pharmaceuticals Corp. — FEI 3010402750

The FDA completed an inspection of Biotest Pharmaceuticals Corp. on February 7, 2014 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Orlando, FL (United States)